申请人:BOYLAN John Frederick
公开号:US20130079383A1
公开(公告)日:2013-03-28
The invention relates to the compounds of formula I:
and pharmaceutically acceptable salts and esters thereof, wherein n, G, W, X, Y, and R1 are defined in the detailed description and claims. The compounds of formula I bind to or associate with VLA-4 and can be used in delivery formulations to deliver drugs, nucleic acids, or other therapeutic compounds to tissues or cells expressing VLA-4.
这项发明涉及公式I的化合物:
以及其药用可接受的盐和酯,其中n、G、W、X、Y和R1在详细说明和索赔中有定义。公式I的化合物与VLA-4结合或与之相关,并可用于传递制剂,将药物、核酸或其他治疗化合物传递到表达VLA-4的组织或细胞中。